The report on the Global Active Pharmaceutical Ingredients (API) Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of a comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
Drivers
TABLE OF CONTENTS
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Active Pharmaceutical Ingredients Market
2.2. Global Active Pharmaceutical Ingredients Market Snapshot
3 . ACTIVE PHARMACEUTICAL INGREDIENTS – INDUSTRY ANALYSIS
3.1. Introduction
3.2. Market Drivers of Active Pharmaceutical Ingredients Market
3.3. Market Restraints of Active Pharmaceutical Ingredients Market
3.4. Opportunities of Active Pharmaceutical Ingredients Market
3.5. Trends of Active Pharmaceutical Ingredients Market
3.6. Porter’s Five Force Analysis of Active Pharmaceutical Ingredients Market
3.7. Active Pharmaceutical Ingredients Market Attractiveness Analysis
3.7.1 Market Attractive Analysis by Type
3.7.2 Market Attractive Analysis by Manufacturer Type
3.7.3 Market Attractive Analysis by Synthesis Type
3.7.4 Market Attractive Analysis by Application
3.7.5 Market Attractive Analysis by Region
4 . VALUE CHAIN ANALYSIS
4.1. Active Pharmaceutical Ingredients Value Chain Analysis
4.2. Active Pharmaceutical Ingredients Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Active Pharmaceutical Ingredients Raw Material Manufactures List
4.2.3. Price Trend of Active Pharmaceutical Ingredients Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET ANALYSIS BY TYPE
5.1 Overview by Type
5.2 Global Active Pharmaceutical Ingredients Market Analysis by Type
5.3 Market Analysis of Innovative APIs by Regions
5.4 Market Analysis of Generic APIs by Regions
6 . GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET ANALYSIS BY MANUFACTURER TYPE
6.1 Overview by Manufacturer Type
6.2 Global Active Pharmaceutical Ingredients Market Analysis by Manufacturer Type
6.3 Market Analysis of Captive Manufacturers by Regions
6.4 Market Analysis of Merchant API Manufacturers by Regions
7 . GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET ANALYSIS BY SYNTHESIS TYPE
7.1 Overview by Synthesis Type
7.2 Global Active Pharmaceutical Ingredients Market Analysis by Synthesis Type
7.3 Market Analysis of Synthetic Active Pharmaceutical Ingredients by Regions
7.4 Market Analysis of Biotech Active Pharmaceutical Ingredients by Regions
8 . GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET ANALYSIS BY APPLICATION
8.1 Overview by Application
8.2 Global Active Pharmaceutical Ingredients Market Analysis by Application
8.3 Market Analysis of Oncology by Regions
8.4 Market Analysis of Cardiovascular Disease by Regions
8.5 Market Analysis of Diabetes by Regions
8.6 Market Analysis of Central Nervous System and Neurological Disorders by Regions
8.7 Market Analysis of Endocrinology by Regions
8.8 Market Analysis of Other by Regions
9 . GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET ANALYSIS BY GEOGRAPHY
9.1. Regional Outlook
9.2. Introduction
9.3. North America
9.3.1. Overview
9.3.2. North America Active Pharmaceutical Ingredients Market Estimate by Country
9.3.3. United State
9.3.4. Rest of North America
9.4. Europe
9.4.1. Overview
9.4.2. Europe Active Pharmaceutical Ingredients Market Estimate by Market Segment
9.4.3. Europe Active Pharmaceutical Ingredients Market Estimate by Country
9.4.4. United Kingdom
9.4.5. France
9.4.6. Germany
9.4.7 Rest of Europe
9.5. Asia Pacific
9.5.1. Overview
9.5.2. Asia Pacific Active Pharmaceutical Ingredients Market Estimate by Market Segment
9.5.3. Asia Pacific Active Pharmaceutical Ingredients Market Estimate by Country
9.5.4. China
9.5.5. Japan
9.5.6. India
9.5.7. Rest of Asia Pacific
9.6. Latin America
9.6.1. Overview
9.6.2. Latin America Active Pharmaceutical Ingredients Market Estimate by Market Segment
9.6.3. Latin America Active Pharmaceutical Ingredients Market Estimate by Country
9.6.4. Brazil
9.6.5. Rest of Latin America
9.7. Middle East & Africa
9.7.1. Overview
9.7.2. Middle East & Africa Active Pharmaceutical Ingredients Market Estimate by Market Segment
9.7.3. Middle East & Africa Active Pharmaceutical Ingredients Market Estimate by Country
9.7.4. Middle East
9.7.5. Africa
10 COMPETITIVE LANDSCAPE OF THE ACTIVE PHARMACEUTICAL INGREDIENTS COMPANIES
10.1. Active Pharmaceutical Ingredients Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments
11 COMPANY PROFILES OF ACTIVE PHARMACEUTICAL INGREDIENTS INDUSTRY
11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. AbbVie Inc.
11.3.1. Company Overview
11.3.2. Financials
11.3.3. Products
11.3.4. Recent Developments
11.4. AstraZeneca plc
11.4.1. Company Overview
11.4.2. Financials
11.4.3. Products
11.4.4. Recent Developments
11.5. Bristol-Myers Squibb Company
11.5.1. Company Overview
11.5.2. Financials
11.5.3. Products
11.5.4. Recent Developments
11.6. C. H. Boehringer Sohn AG & Co. KG
11.6.1. Company Overview
11.6.2. Financials
11.6.3. Products
11.6.4. Recent Developments
11.7. Eli Lilly and Company
11.7.1. Company Overview
11.7.2. Financials
11.7.3. Products
11.7.4. Recent Developments
11.8. GlaxoSmithKline plc
11.8.1. Company Overview
11.8.2. Financials
11.8.3. Products
11.8.4. Recent Developments
11.9. Merck & Co., Inc.
11.9.1. Company Overview
11.9.2. Financials
11.9.3. Products
11.9.4. Recent Developments
11.10. Mylan N.V
11.10.1. Company Overview
11.10.2. Financials
11.10.3. Products
11.10.4. Recent Developments
11.11. Novartis International AG
11.11.1. Company Overview
11.11.2. Financials
11.11.3. Products
11.11.4. Recent Developments
11.12. Pfizer Inc.
11.12.1. Company Overview
11.12.2. Financials
11.12.3. Products
11.12.4. Recent Developments
11.13. Sanofi S.A.
11.13.1. Company Overview
11.13.2. Financials
11.13.3. Products
11.13.4. Recent Developments
11.14. Teva Pharmaceutical Industries Ltd.
11.14.1. Company Overview
11.14.2. Financials
11.14.3. Products
11.14.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
The report on the Global Tigecycline Market gives an estimation of the development of the market based on historical studies and also provides forecasts read more..
The Global Risperidone Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks read more..
The report on the Global Caffeine Market gives an estimation of the development of the market based on historical studies and also provides forecasts on read more..
The report on the Global Rabies Vaccine Market gives an estimation of the development of the market based on historical studies and also provides read more..
Radiopharmaceuticals Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under read more..
The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also read more..
The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and read more..
The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and read more..
The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013. A number of factors such as increasing bone related read more..
The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also read more..